University of Pittsburgh Cancer Institute (UPCI)

Career Development Program (CDP)

Co-Leaders: Kirsten Moysich, PhD; Shashikant Lele, MD, FACOG; Francesmary Modugno, PhD, MPH

Year 1 CDP Projects:

  • Development of a novel immunotherapeutic strategy for ovarian cancer patients using tumor-recognizing CD4+ T cells. (Junko Matsuzaki, PhD)
  • Overcoming ovarian cancer-associated immunosuppression by regulating Th17/Treg plasticity. (Natasa Obermajer, PhD)

Developmental Research Program (DRP)

Co-Leaders: Kirsten Moysich, PhD; Robert P. Edwards, MD; Francesmary Modugno, PhD, MPH

Year 1 DRP Projects:

  • Infection in the etiology of ovarian cancer. (Jo Freudenheim, PhD)
  • Invasive ovarian cancer models for treatment with oncolytic virotherapy. (Danuta Kozbor, PhD)
  • Evaluation of novel immune biomarkers for ovarian cancer. (Brahm Segal, MD)
  • Inflammation and intratumoral immune checkpoint activity in ovarian cancer. (Anda Vlad, MD, PhD)